Latest Period
Q2 2026
Security Snapshot
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) Institutional Ownership
CUSIP: 29251M106
13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026
Institutions Reporting
121
Shares (Excl. Options)
27,254,671
Price
$14.58
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.01 per share
- Symbol
- ENTA on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 27,254,671
- Total 13F value
- $397,229,857
- Portfolio coverage rank
- 0%
- Share change
- +646,101
- Value change
- +$9,928,221
- Number of holders
- 121
- Shares outstanding
- 29,057,686
- SEC-reported price per share
- $13.19
- Insider filing price
- $13.19
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share is tracked under CUSIP 29251M106.
- 121 institutions reported positions in Q2 2026.
- 7 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 132 to 121 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $338,104,569 to $397,229,857.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 121 institutions filings for Q2 2026.
Security key
29251M106
Latest holder period
Q2 2026
13F holders
121
13D/G owners
7
CIK / CUSIP context first
Open Q2 2026 holders
ENTA full holder history
ENANTA PHARMACEUTICALS INC SEC filings
ENANTA PHARMACEUTICALS INC company facts
ENANTA PHARMACEUTICALS INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 29251M106:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
7
Security
ENTA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 12% | $41,823,994 | 3,494,068 | JANUS HENDERSON GROUP PLC | 31 Oct 2025 | |||
| Farallon Capital Partners, L.P. | 9.8% | -1% | $44,421,914 | +$11,174,622 | 2,816,862 | +34% | Dapice Joshua J. | 31 Dec 2025 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 8.3% | $35,088,111 | 2,418,202 | Farallon Capital Management, L.L.C. | 30 Jun 2026 | |||
| Luly Jay R. | 7.7% | $9,659,503 | 1,703,616 | Jay R. Luly, Ph.D. | 12 Feb 2025 | |||
| BlackRock, Inc. | 7.8% | $9,488,649 | 1,673,483 | BlackRock, Inc. | 31 Mar 2025 | |||
| Deep Track Capital, LP | 5% | -26% | $20,954,863 | -$7,439,277 | 1,444,167 | -26% | Deep Track Capital, LP | 30 Jun 2026 |
| INTEGRATED CORE STRATEGIES (US) LLC | 2.3% | -45% | $10,572,650 | -$7,381,243 | 670,428 | -41% | Millennium Management LLC | 31 Dec 2025 |
As of 30 Jun 2026, 121 institutional investors reported holding 27,254,671 shares of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA). This represents 94% of the company’s total 29,057,686 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
86%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Jupiter Topco LLC | 13% | 3,654,920 | 0% | 0.02% | $53,252,184 |
| BlackRock, Inc. | 11% | 3,244,448 | +4.5% | 0% | $47,304,051 |
| Krensavage Asset Management, LLC | 9.9% | 2,866,138 | 0% | 16% | $41,788,000 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 8.3% | 2,418,202 | -16% | 0.21% | $35,257,385 |
| Deep Track Capital, LP | 5% | 1,444,167 | -26% | 0.31% | $21,055,955 |
| ADAR1 Capital Management, LLC | 4.6% | 1,344,510 | +2518% | 0.93% | $19,602,956 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 1,211,769 | +2.9% | 0% | $17,667,592 |
| Spruce Street Capital LP | 3.7% | 1,088,731 | +17% | 3.1% | $15,873,698 |
| ACADIAN ASSET MANAGEMENT LLC | 3.7% | 1,078,317 | +23% | 0.02% | $15,706,000 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.5% | 1,011,494 | +6.6% | 0% | $14,747,583 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.7% | 776,634 | +7.1% | 0% | $11,325,842 |
| MILLENNIUM MANAGEMENT LLC | 2.2% | 643,967 | -27% | 0.01% | $9,389,039 |
| STATE STREET CORP | 2% | 576,117 | +2.5% | 0% | $8,399,786 |
| RENAISSANCE TECHNOLOGIES LLC | 1.9% | 557,600 | -16% | 0.01% | $8,129,808 |
| Hillsdale Investment Management Inc. | 1.6% | 468,000 | +7.5% | 0.16% | $6,823,440 |
| GOLDMAN SACHS GROUP INC | 1.6% | 464,649 | +75% | 0% | $6,774,583 |
| MORGAN STANLEY | 1.1% | 315,729 | +2% | 0% | $4,603,338 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1% | 301,151 | +2.1% | 0% | $4,390,782 |
| DIMENSIONAL FUND ADVISORS LP | 0.97% | 282,682 | +39% | 0% | $4,121,427 |
| NORTHERN TRUST CORP | 0.89% | 259,696 | +7.8% | 0% | $3,786,368 |
| SummitTX Capital, L.P. | 0.89% | 257,702 | 0.1% | $3,757,295 | |
| AQR CAPITAL MANAGEMENT LLC | 0.88% | 256,870 | -18% | 0% | $3,745,165 |
| VANGUARD FIDUCIARY TRUST CO | 0.64% | 185,618 | +5.6% | 0% | $2,706,310 |
| Connor, Clark & Lunn Investment Management Ltd. | 0.53% | 153,008 | +22% | 0% | $2,230,857 |
| Rockefeller Capital Management L.P. | 0.52% | 150,546 | +5774% | 0% | $2,194,960 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 27,254,671 | $397,229,857 | +$9,928,221 | $14.58 | 121 |
| 2026 Q1 | 26,772,675 | $338,104,569 | +$2,308,887 | $12.63 | 132 |
| 2025 Q4 | 26,389,999 | $416,082,980 | +$116,200,977 | $15.77 | 130 |
| 2025 Q3 | 18,990,953 | $227,099,660 | +$8,889,718 | $11.97 | 119 |
| 2025 Q2 | 18,415,589 | $139,218,163 | -$1,130,233 | $7.56 | 103 |
| 2025 Q1 | 18,625,766 | $102,810,306 | -$7,313,392 | $5.52 | 108 |
| 2024 Q4 | 19,907,432 | $114,464,576 | -$17,702,481 | $5.75 | 105 |
| 2024 Q3 | 21,229,862 | $219,956,486 | -$10,189,778 | $10.36 | 110 |
| 2024 Q2 | 22,131,926 | $287,039,395 | -$4,639,003 | $12.97 | 99 |
| 2024 Q1 | 22,403,789 | $391,166,955 | +$45,279,493 | $17.46 | 105 |
| 2023 Q4 | 20,026,111 | $188,441,196 | -$5,171,233 | $9.41 | 103 |
| 2023 Q3 | 20,144,110 | $225,005,701 | -$8,699,698 | $11.17 | 129 |
| 2023 Q2 | 19,936,779 | $426,629,256 | -$15,765,200 | $21.40 | 129 |
| 2023 Q1 | 19,836,693 | $802,018,224 | +$23,678,858 | $40.44 | 142 |
| 2022 Q4 | 19,243,859 | $895,247,833 | -$44,744,222 | $46.52 | 145 |
| 2022 Q3 | 19,726,320 | $1,023,129,229 | -$26,641,297 | $51.87 | 155 |
| 2022 Q2 | 20,231,748 | $956,338,910 | +$17,270,558 | $47.27 | 149 |
| 2022 Q1 | 19,671,490 | $1,399,487,075 | +$60,693,984 | $71.18 | 163 |
| 2021 Q4 | 18,780,733 | $1,403,536,269 | -$51,376,670 | $74.78 | 172 |
| 2021 Q3 | 19,379,501 | $1,101,045,074 | +$34,578,566 | $56.81 | 140 |
| 2021 Q2 | 18,825,846 | $828,634,567 | -$26,899,911 | $44.01 | 147 |
| 2021 Q1 | 19,430,818 | $956,710,887 | +$7,403,943 | $49.32 | 146 |
| 2020 Q4 | 19,261,435 | $811,015,243 | +$16,262,569 | $42.10 | 148 |
| 2020 Q3 | 18,857,563 | $863,147,048 | +$27,242,369 | $45.78 | 170 |
| 2020 Q2 | 18,268,221 | $917,098,781 | +$10,521,228 | $50.21 | 173 |